BR100 Decreased By (-1%)
BR30 Decreased By (-1.47%)
KSE100 Decreased By (-0.95%)
KSE30 Decreased By (-1.02%)
AGHA 6.34 Decreased By ▼ -0.06 (-0.94%)
BECO 3.99 Decreased By ▼ -0.09 (-2.21%)
BML 58.71 Increased By ▲ 0.84 (1.45%)
BOP 27.30 Decreased By ▼ -0.62 (-2.22%)
CNERGY 12.40 Increased By ▲ 0.05 (0.4%)
CSIL 5.09 Increased By ▲ 0.07 (1.39%)
FCCL 49.65 Decreased By ▼ -0.37 (-0.74%)
FFL 13.36 Decreased By ▼ -0.27 (-1.98%)
FNEL 1.07 Decreased By ▼ -0.01 (-0.93%)
KEL 5.55 Decreased By ▼ -0.08 (-1.42%)
KOSM 5.10 No Change ▼ 0.00 (0%)
LOTCHEM 23.04 Decreased By ▼ -0.89 (-3.72%)
MLCF 86.63 Decreased By ▼ -0.91 (-1.04%)
NBP 149.69 Decreased By ▼ -3.64 (-2.37%)
NCPL 48.17 Decreased By ▼ -0.88 (-1.79%)
NPL 53.56 Decreased By ▼ -0.98 (-1.8%)
OGDC 298.12 Decreased By ▼ -2.38 (-0.79%)
PACE 9.23 Decreased By ▼ -0.06 (-0.65%)
PAEL 32.05 Decreased By ▼ -0.72 (-2.2%)
PIBTL 12.55 Decreased By ▼ -0.31 (-2.41%)
PPL 210.17 Decreased By ▼ -4.03 (-1.88%)
PRL 94.52 Decreased By ▼ -0.60 (-0.63%)
PTC 45.29 Decreased By ▼ -1.78 (-3.78%)
SSGC 22.52 Decreased By ▼ -0.03 (-0.13%)
TBL 8.67 Decreased By ▼ -0.12 (-1.37%)
TELE 6.66 Decreased By ▼ -0.08 (-1.19%)
TPL 21.61 Increased By ▲ 1.12 (5.47%)
TPLP 11.51 Increased By ▲ 0.23 (2.04%)
TREET 22.17 Decreased By ▼ -0.58 (-2.55%)
TRG 52.54 Decreased By ▼ -2.19 (-4%)
world Print edition: 2026-08-23

More than 16,000 doses of Ervebo vaccine arrive in Ebola-hit DRC

Published Updated
Photo: Reuters
Photo: Reuters
By

KINSHASA: More than 16,000 doses of the Ervebo vaccine arrived in the Democratic Republic of Congo (DRC) late Friday, an AFP journalist saw, as the country faces the deadliest Ebola outbreak in its history.

The DRC’s 17th Ebola outbreak, which has killed thousands of people, was declared on May 15 but is thought to have been spreading for several weeks prior. It has hit regions in the north and east where the presence of the state is weak, health infrastructure is largely lacking and myriad armed groups have roamed for decades. The World Health Organization (WHO) announced on Thursday that the DRC would receive a total of 70,000 doses of the Ervebo vaccine, produced in Germany.

The vaccine, developed by the pharmaceutical company Merck, is approved against the Zaire strain of the virus, but not against the Bundibugyo strain currently circulating in the country. WHO experts still do not know whether Ervebo protects humans against the Bundibugyo strain, but early data, notably from animal trials, suggest it could offer some protection. The Ervebo vaccine “has already been used several times, and in particular on a very large scale during the 2018-2020 outbreak”, Samuel Roger Kamba, the DRC’s minister of health, told the press. He was speaking on the tarmac of Kinshasa airport, where a batch of 16,250 doses was delivered by plane on Friday.

Of the 70,000 doses made available to the DRC, 20,000 are intended for a clinical trial, and 50,000 for “frontline and health workers” in the DRC, the WHO explained on Thursday. The Ebola outbreak in the DRC has already caused 2,516 deaths among 5,290 confirmed cases, according to the latest data published by the Congolese authorities. It “is growing exponentially”, warned Julien Harneis, the UN’s senior Ebola coordinator, on Friday.

This month, WHO vaccine experts recommended a full-scale human trial of Ervebo, the only existing approved Ebola vaccine, to see if it offered cross-protection against the Bundibugyo strain.

Comments

200 characters remaining